Lucy Jenner’s Post

Check out how the Wazoku Crowd is accelerating research outcomes with International FOP Association in our latest blog post. FOP is an ultra-rare, progressively disabling, genetic disorder with no cure.The IFOPA is launching a Wazoku Crowd Challenge, using fresh eyes, open innovation, and crowdsourcing to tackle significant hurdles in FOP Research and Development. Learn more by clicking the link below! #Innovation #Research #Crowdsourcing

Check out how the Wazoku Crowd is accelerating research outcomes with International FOP Association in our latest blog post. FOP is an ultra-rare, progressively disabling, genetic disorder with no cure.The IFOPA is launching a Wazoku Crowd Challenge, using fresh eyes, open innovation, and crowdsourcing to tackle significant hurdles in FOP Research and Development. Learn more by clicking the link below! #Innovation #Research #Crowdsourcing

Check out how the Wazoku Crowd is accelerating research outcomes with International FOP Association in our latest blog post. FOP is an ultra-rare, progressively disabling, genetic disorder with no cure.The IFOPA is launching a Wazoku Crowd Challenge, using fresh eyes, open innovation, and crowdsourcing to tackle significant hurdles in FOP Research and Development. Learn more by clicking the link below! #Innovation #Research #Crowdsourcing

Check out how the Wazoku Crowd is accelerating research outcomes with International FOP Association in our latest blog post. FOP is an ultra-rare, progressively disabling, genetic disorder with no cure. The IFOPA is launching a Wazoku Crowd Challenge, using fresh eyes, open innovation, and crowdsourcing to tackle significant hurdles in FOP Research and Development. Learn more by clicking the link below! #Innovation #Research #Crowdsourcing

Genomes By Design new gene editing method could allow an “unprecedented level of control for manipulating genomes.” The existing CRISPR-Cas9 technique allows snippets of genetic code to be cut and replaced with precision. But it only allows small cuts and changes, and works by damaging the target. The new “bridge editing” system, which like CRISPR uses molecular machinery found in bacteria, allows huge sections of a genome to be altered: One researcher told New Scientist that it would allow scientists to “move beyond inserting individual genes to do chromosome-scale genome engineering.” It has not yet been shown to work in human cells, but even if it does not, will likely be modified so that it can.

Evo is a genomic Foundation Model with 7 billion parameters and a context length of 131 kilobases, trained on whole prokaryotic genomes. It utilizes deep signal processing advances for predicting and generating molecular to genome-scale tasks. Evo generalizes across molecular biology's central dogma, performing competitively in zero-shot function prediction and excelling in multi-element generation tasks, including creating synthetic CRISPR-Cas complexes and transposable systems. It can predict gene essentiality at nucleotide resolution and generate long coding-rich sequences, significantly surpassing previous methods. Evo's multi-modal and multi-scale learning advancements offer a promising avenue for enhancing our mechanistic understanding and generative capabilities in biology. https://lnkd.in/ghAmSqfQ

How can #philanthropy and #artificialintelligence advance precision medicine research for neurodegenerative diseases? Check out this comprehensive report by Caitlyn Barrett! #AI #neurodegenerativedisease #neurodegeneration

For anyone interested in AI and the path to precision medicine for neurodegenerative diseases, my colleague, Caitlyn Barrett wrote this terrific guide!

Between July 2021 and July 2022 psychedelics-related start-ups raised over $236 million, and now researchers are starting to get funding for their studies. This PLI Chronicle article, authored by Edgar J. Asebey and Jim O'Reilly, provides a brief history of psychedelics, including their use in breakthrough therapies, and looks at the regulatory landscape ahead. Read the article today: https://bddy.me/4b3zoHh

🔬The Ehlers-Danlos Society is excited to announce the development of an EDS and HSD Biobank. Thanks to a generous $2.5 million donation from the Mike and Sofia Segal Foundation, this biobank represents a significant advancement for researchers studying Ehlers-Danlos syndromes (EDS) and hypermobility spectrum disorders (HSD). 🧪The biobank will be a crucial resource for learning more about the types of EDS and HSD. It will help researchers study these conditions to find better ways to diagnose, treat, and care for people with them. 🧬By giving scientists access to a variety of biological samples and information about people’s health concerns, it will help them dig deeply into what causes these conditions and how to help people who have them. Learn more about this exciting research update here: https://lnkd.in/eQB3KUi3 #EhlersDanlosSyndrome #Hypermobility #HypermobilitySpectrumDisorder #ZebraStrong #Research #Biobank #EDS #HSD #Scientists